Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

Zhuo-Yuan Lin; Guo Chen; Yan-Qiong Zhang; Hui-Chan He; Yu-Xiang Liang; Jian-Heng Ye; Ying-Ke Liang; Ru-Jun Mo; Jian-Ming Lu; Yang-Jia Zhuo; Yu Zheng; Fu-Neng Jiang; Zhao-Dong Han; Shu-Lin Wu; Wei-de Zhong; Chin-Lee Wu

doi:10.1186/s12943-019-1051-x

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

Mol Cancer. 2019 Aug 6;18(1):122. doi: 10.1186/s12943-019-1051-x.

Authors

Zhuo-Yuan Lin^{1

2}, Guo Chen¹, Yan-Qiong Zhang^{3

4

5}, Hui-Chan He¹, Yu-Xiang Liang¹, Jian-Heng Ye^{1

4

5}, Ying-Ke Liang^{1

6}, Ru-Jun Mo^{1

6}, Jian-Ming Lu^{1

6}, Yang-Jia Zhuo^{1

6}, Yu Zheng^{2

6}, Fu-Neng Jiang¹, Zhao-Dong Han¹, Shu-Lin Wu^{4

5}, Wei-de Zhong^{7

8

9

10}, Chin-Lee Wu^{11

12

13}

Affiliations

¹ Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, 510180, China.
² Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 510260, China.
³ Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
⁴ Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
⁵ Department of Urology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
⁶ Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
⁷ Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, 510180, China. zhongwd2009@live.cn.
⁸ Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. zhongwd2009@live.cn.
⁹ Urology Key Laboratory of Guangdong Province, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 510230, China. zhongwd2009@live.cn.
¹⁰ Graduate school of Jinan University, Guangzhou, 510632, China. zhongwd2009@live.cn.
¹¹ Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, 510180, China. cwu2@mgh.harvard.edu.
¹² Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. cwu2@mgh.harvard.edu.
¹³ Department of Urology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. cwu2@mgh.harvard.edu.

Abstract

After publication of the article [1], the author reported that this article contained some errors.

Publication types

Published Erratum